1. Lévy X, Nizanski W, von Heimendahl A, et al. Diagnosis of common prostatic conditions in dogs: an update. Reprod Domest Anim 2014;49(suppl 2):50–57.
2. Weaver AD. Fifteen cases of prostatic carcinoma in the dog. Vet Rec 1981;109:71–75.
3. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 2000;45:173–183.
4. Torres de la Riva G, Hart BL, Farver TB, et al. Neutering dogs: effects on joint disorders and cancers in Golden Retrievers. PLoS One 2013;8:e55937.
5. Leroy BE, Northrup N. Prostate cancer in dogs: comparative and clinical aspects. Vet J 2009;180:149–162.
6. Vignoli M, Russo M, Catone G, et al. Assessment of vascular perfusion kinetics using contrast-enhanced ultrasound for the diagnosis of prostatic disease in dogs. Reprod Domest Anim 2011;46:209–213.
7. Bonekamp D, Jacobs MA, El-Khouli R, et al. Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics 2011;31:677–703.
8. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000;55:99–109.
9. Padhani AR, Harvey CJ, Cosgrove DO. Angiogenesis imaging in the management of prostate cancer. Nat Clin Pract Urol 2005;2:596–607.
10. Somford DM, Futterer JJ, Hambrock T, et al. Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 2008;16:685–695, ix.
11. Esen M, Onur MR, Akpolat N, et al. Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis. Quant Imaging Med Surg 2013;3:210–216.
12. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002;16:196–200.
13. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011;259:453–461.
14. Nagarajan R, Margolis D, Raman S, et al. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol 2012;2012:374805.
15. Mattoon JS, Nyland TG. Prostate and testes. In: Nyland TG, Mattoon JS, eds. Small animal diagnostic ultrasound. Philadelphia: WB Saunders, 2002;250–266.
16. Günzel-Apel AR, Mohrke C, Poulsen Nautrup C. Colour-coded and pulsed Doppler sonography of the canine testis, epididymis and prostate gland: physiological and pathological findings. Reprod Domest Anim 2001;36:236–240.
17. Powe JR, Canfield PJ, Martin PA. Evaluation of the cytologic diagnosis of canine prostatic disorders. Vet Clin Pathol 2004;33:150–154.
18. Paclikova K, Kohout P, Vlasin M. Diagnostic possibilities in the management of canine prostatic disorders. Vet Med (Praha) 2006;51:1–13.
19. Yung AC, Oner AY, Serfaty JM, et al. Phased-array MRI of canine prostate using endorectal and endourethral coils. Magn Reson Med 2003;49:710–715.
20. Susil RC, Krieger A, Derbyshire JA, et al. System for MR image-guided prostate interventions: canine study. Radiology 2003;228:886–894.
21. Sun F, Baez-Diaz C, Sanchez-Margallo FM. Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models. Transl Androl Urol 2017;6:538–546.
22. Chen Y, Xu S, Squires A, et al. MRI guided robotically assisted focal laser ablation of the prostate using canine cadavers. IEEE Trans Biomed Eng 2018;65:1434–1442.
23. Cheng HL, Haider MA, Dill-Macky MJ, et al. MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: an in vivo canine study. J Magn Reson Imaging 2008;28:136–143.
24. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347–357.
25. Lai CL, van den Ham R, van Leenders G, et al. Comparative characterization of the canine normal prostate in intact and castrated animals. Prostate 2008;68:498–507.
26. Barrett T, Priest AN, Lawrence EM, et al. Ratio of tumor to normal prostate tissue apparent diffusion coefficient as a method for quantifying DWI of the prostate. AJR Am J Roentgenol 2015;205:W585–W593.
27. Kim CK, Park BK, Kim B. Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 2010;194:1461–1469.
28. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007;63:335–350.
29. Hara N, Okuizumi M, Koike H, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 2005;62:140–147.
30. Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241:449–458.
31. Haider MA, Chung P, Sweet J, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:425–430.
32. Jones DJ, Stehling LC, Zauder HL. Cardiovascular responses to diazepam and midazolam maleate in the dog. Anesthesiology 1979;51:430–434.
33. Lowseth LA, Gerlach RF, Gillett NA, et al. Age-related changes in the prostate and testes of the Beagle dog. Vet Pathol 1990;27:347–353.
34. Ren J, Huan Y, Wang H, et al. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging 2008;33:724–728.
Advertisement
To describe diffusion and perfusion characteristics of the prostate gland of healthy sexually intact adult dogs as determined by use of diffusion-weighted and perfusion-weighted MRI.
12 healthy sexually intact adult Beagles.
Ultrasonography of the prostate gland was performed. Subsequently, each dog was anesthetized, and morphological, diffusion-weighted, and perfusion-weighted MRI of the caudal aspect of the abdomen was performed. The apparent diffusion coefficient was calculated for the prostate gland parenchyma in diffusion-weighted MRI images in the central ventral and peripheral dorsal areas. Perfusion variables were examined in multiple regions of interest (ROIs) in the ventral and dorsal areas of the prostate gland and in the gluteal musculature. Signal intensity was determined, and a time-intensity curve was generated for each ROI.
Results of ultrasonographic examination of the prostate gland revealed no abnormalities for any dog. Median apparent diffusion coefficient of the prostate gland was 1.51 × 10−3 mm2/s (range, 1.04 × 10−3 mm2/s to 1.86 × 10−3 mm2/s). Perfusion-weighted MRI variables for the ROIs differed between the prostate gland parenchyma and gluteal musculature.
Results provided baseline information about diffusion and perfusion characteristics of the prostate gland in healthy sexually intact adult dogs. Additional studies with dogs of various ages and breeds, with and without abnormalities of the prostate gland, will be necessary to validate these findings and investigate clinical applications.
Dr. Willmitzer's present address is VET Zentrum AG, Riedäckerstrasse 7, 8422 Winterthur, Switzerland.
Drs. Willmitzer and Del Chicca contributed equally to the manuscript.